Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

Impact of Concurrent Indolent Lymphoma on the Clinical Outcome of Newly Diagnosed Diffuse Large B-Cell Lymphoma

(2019) Yucai Wang et al.   BLOOD

Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma

(2019) Anja Mottok et al.   BLOOD

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort

(2018) Alexandra Smith et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

(2018) Bjoern Chapuy et al.   NATURE MEDICINE

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

(2018) Roland Schmitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetics of Diffuse Large B-Cell Lymphoma

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based Haematological Malignancy Research Network

(2018) Daniel Painter et al.   BRITISH JOURNAL OF HAEMATOLOGY

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy

(2018) Chulin Sha et al.   JOURNAL OF CLINICAL ONCOLOGY

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

(2017) K Karube et al.   LEUKEMIA

2016 US lymphoid malignancy statistics by World Health Organization subtypes

(2016) Lauren R. Teras et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

(2015) Ji Yuan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network

(2015) A Smith et al.   BRITISH JOURNAL OF CANCER

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients

(2014) N. F. C. C. de Miranda et al.   BLOOD

Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing

(2013) R. D. Morin et al.   BLOOD

Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma

(2012) Stefano Monti et al.   CANCER CELL

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

(2012) J. G. Lohr et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

(2011) Ryan D. Morin et al.   NATURE

Analysis of the coding genome of diffuse large B-cell lymphoma

(2011) Laura Pasqualucci et al.   NATURE GENETICS

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research

(2009) Alexandra Smith et al.   BRITISH JOURNAL OF HAEMATOLOGY